Key takeaways:
Apolipoprotein B (ApoB) is a protein that’s found on the surface of certain cholesterol and fat-carrying particles.
High ApoB puts you at higher risk for heart attack and stroke, even if your low-density lipoprotein (LDL) or “bad” cholesterol is in a normal range.
A healthy lifestyle, nutritious diet, and cholesterol-lowering medications can all help to lower your ApoB level.
You probably know that high levels of low-density lipoprotein (LDL), or the “bad” cholesterol, can raise your risk for heart attack and stroke. But you may not have heard about apolipoprotein B (ApoB).
The usual numbers in your cholesterol test (lipid profile) may leave out this important measure of your risk for heart disease. Scientists and lipid specialists have known about the harms of high ApoB for years, but it’s getting more attention now. For people who are at risk for heart disease, it may be an important number to know.
In this article, we look into ApoB, what causes its high levels, what you need to lower it, and how to test for it.
What is apolipoprotein B?
Apolipoprotein B (ApoB) is a protein found on the surface of certain particles in your blood. You can think of these particles as tiny packages that carry cholesterol and fat. This is an important process that helps deliver energy to your muscles and other organs. But problems can happen when there are too many ApoB-containing particles in the blood.
ApoB is found on particles that can cause plaque to build up in your arteries. LDL cholesterol — the “bad” type of cholesterol — is one of these particles. Over time, plaque (atherosclerosis) can narrow your arteries and create blockages. These blockages are what cause heart attacks and strokes.
What do high apolipoprotein B levels mean?
A high ApoB level means there are a lot of harmful cholesterol-carrying particles in your blood. In general, having more particles means you are at greater risk for heart attack and stroke.
A target (or “good”) ApoB level depends on your risk for heart disease. In general, many experts aim for:
ApoB below 100 mg/dL for people at moderate risk
ApoB below 80 mg/dL for people at high risk
ApoB below 65 mg/dL for people at very high risk
A high ApoB level means something a little different from the usual measurement of LDL cholesterol. Your LDL cholesterol number tells you how much cholesterol is being carried inside the LDL particles. But it doesn’t tell you exactly how many particles are carrying that cholesterol. ApoB helps answer that question. It gives a better estimate of the total number of plaque-forming particles circulating in your blood.
Add GoodRx as a trusted source on GoogleAdd GoodRx as a trusted sourceWhat causes high apolipoprotein B levels?
Here are the main reasons that people have high ApoB levels:
Genetics
Insulin resistance, which is often linked to prediabetes, Type 2 diabetes, and metabolic syndrome
A diet high in refined carbohydrates, added sugars, excess calories, and saturated fat
Lack of regular exercise
Having obesity
Hypothyroidism (low levels of thyroid hormone)
Kidney disease
Steroids, including anabolic steroids
There are a few medications — including certain older beta blockers, some thiazide diuretics, and some older HIV medicines — that may affect ApoB levels in some individuals. If you’re taking one of these and your ApoB is high, check with your healthcare professional to see if there might be an alternative.
How do you lower apolipoprotein B?
Many of the same steps that lower LDL cholesterol can also lower ApoB. These include:
Following a heart-healthy Mediterranean way of eating
Limiting food high in saturated fats like butter, coconut oil, and fatty meats
Doing regular exercise
Maintaining a healthy body weight
Limiting alcohol
The medications that lower LDL cholesterol also improve ApoB. These include:
Statins (Crestor, Lipitor, Pravachol, and others)
PCSK9 inhibitors (Repatha, Praluent, Leqvio, Lerochol)
Bempedoic acid (Nexletol)
Ezetimibe (Zetia), especially when combined with a statin
A few stronger specialty medications can also lower ApoB, including lomitapide (Juxtapid) and evinacumab (Evkeeza). These are usually used only for rare genetic cholesterol disorders, such as homozygous familial hypercholesterolemia. They aren’t used for most people with mildly or moderately high ApoB.
It’s likely that in the future more medications that target ApoB will become available.
Who needs an apolipoprotein B test?
Not everyone needs an ApoB test. For many people, the usual cholesterol panel gives enough information to guide care. But ApoB levels can be especially useful for people who have:
High triglycerides
Type 2 diabetes, prediabetes, or metabolic syndrome
Excess weight around the belly
A family history of early heart disease
Known heart disease, especially if LDL is well controlled
A healthcare professional can help you decide if an ApoB test might be useful for you.
Frequently asked questions
Apolipoprotein B (ApoB) is measured with a blood test. It’s not part of the standard lipid profile, but it can often be ordered at the same time. You usually don’t need to fast before your ApoB is checked.
There’s good evidence that high ApoB is more predictive of heart problems than LDL cholesterol. That may be especially true for people with Type 2 diabetes, high triglycerides, or metabolic syndrome. But an ApoB level reading doesn’t replace an LDL measure. Instead, it can add useful information beyond the standard cholesterol numbers.
ApoB levels can be affected by your genetics. For most people, it’s a combination of genes and lifestyle. That means that even if you have genetically high ApoB, there may be important lifestyle changes that you can make to lower your risk. These include eating a heart-healthy diet, doing regular exercise, and avoiding smoking.
Apolipoprotein B (ApoB) is measured with a blood test. It’s not part of the standard lipid profile, but it can often be ordered at the same time. You usually don’t need to fast before your ApoB is checked.
There’s good evidence that high ApoB is more predictive of heart problems than LDL cholesterol. That may be especially true for people with Type 2 diabetes, high triglycerides, or metabolic syndrome. But an ApoB level reading doesn’t replace an LDL measure. Instead, it can add useful information beyond the standard cholesterol numbers.
ApoB levels can be affected by your genetics. For most people, it’s a combination of genes and lifestyle. That means that even if you have genetically high ApoB, there may be important lifestyle changes that you can make to lower your risk. These include eating a heart-healthy diet, doing regular exercise, and avoiding smoking.
The bottom line
A blood test for apolipoprotein B (ApoB) can show how many harmful cholesterol-carrying particles are in your blood. In some people, ApoB can reveal heart risk that a standard cholesterol panel may miss. This is especially true for people with high triglycerides, Type 2 diabetes, metabolic syndrome, or a family history of heart disease.
The good news is that medications that lower LDL or “bad” cholesterol can also help lower ApoB. Lifestyle habits like eating a Mediterranean-style diet, doing regular exercise, maintaining a healthy weight, and not smoking can also help. A healthcare professional can help you decide whether ApoB testing is right for you.
Why trust our experts?


References
American Heart Association. (2026). ACC/American Heart Association issue updated guideline for managing lipids, cholesterol.
American Heart Association. (2026). ApoB: Another look at heart disease risk.
American Heart Association. (2026). Understanding homozygous familial hypercholesterolemia.
Contois, J. H., et al. (2023). Standardization of apolipoprotein B, LDL‐cholesterol, and non‐HDL‐cholesterol. Journal of the American Heart Association.
De Oliveira-Gomes, D., et al. (2024). Apolipoprotein B: Bridging the gap between evidence and clinical practice. Circulation.
Di Minno, A., et al. (2020). Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: Systematic review and meta‐analysis of randomized controlled trials. Journal of the American Heart Association.
Elshazly, M. B., et al. (2022). The lower the ApoB, the better: Now, how does ApoB fit in the upcoming era of targeted therapeutics? Circulation.
Furtado, J. D., et al. (2009). Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial2. The American Journal of Clinical Nutrition.
Hartgens, F., et al. (2004). Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). British Journal of Sports Medicine.
Holme, I., et al. (2007). ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. Journal of Internal Medicine.
Kodjoe, E., et al. (2025). Association between apolipoprotein B and obesity: A cross-sectional analysis of NHANES data. Journal of Clinical Lipidology.
Mach, F., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal.
Marston, N. A., et al. (2022). Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: Distinguishing between particle concentration, type, and content. JAMA Cardiology.
Mugii, S., et al. (2012). Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease. Journal of Atherosclerosis and Thrombosis.
Patel, S., et al. (2025). Apolipoprotein B in the risk assessment, diagnosis, and treatment of cardiometabolic diseases. Cardiology & Cardiovascular Medicine.
Razzack, A. A., et al. (2021). Cardioprotective effects of ezetimibe as an adjunct to statins versus statin up-titration on apolipoproteins for prevention of atherosclerosis- A systematic review and meta analysis. Journal of the American College of Cardiology.
Reeskamp, L. F., et al. (2021). ANGPTL3 inhibition with evinacumab results in faster clearance of IDL and LDL ApoB in patients with homozygous familial hypercholesterolemia—brief report. Arteriosclerosis, Thrombosis, and Vascular Biology.
Romero Kauss, A., et al. (2022). Smoking and apolipoprotein levels: A meta-analysis of published data. Toxicology Reports.
Soffer, D. E., et al. (2024). Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the National Lipid Association. Journal of Clinical Lipidology.











